AAAAAA

   
Results: 1-23 |
Results: 23

Authors: RANCOURT C ROBERTSON MW WANG MH GOLDMAN CK KELLY JF ALVAREZ RD SIEGAL GP CURIEL DT
Citation: C. Rancourt et al., ENDOTHELIAL-CELL VEHICLES FOR DELIVERY OF CYTOTOXIC GENES AS A GENE-THERAPY APPROACH FOR CARCINOMA OF THE OVARY, Clinical cancer research, 4(2), 1998, pp. 265-270

Authors: RANCOURT C ROBERTSON MW WANG MH GOLDMAN CK KELLY JF ALVAREZ RD SIEGAL GP CURIEL DT
Citation: C. Rancourt et al., ENDOTHELIAL-CELL VEHICLES FOR DELIVERY OF CYTOTOXIC GENES AS A GENE-THERAPY APPROACH FOR CARCINOMA OF THE OVARY, Clinical cancer research, 4(2), 1998, pp. 265-270

Authors: GOLDMAN CK KENDALL RL CABRERA G SOROCEANU L HEIKE Y GILLESPIE GY SIEGAL GP MAO XZ BETT AJ HUCKLE WR THOMAS KA CURIEL DT
Citation: Ck. Goldman et al., PARACRINE EXPRESSION OF A NATIVE SOLUBLE VASCULAR ENDOTHELIAL GROWTH-FACTOR RECEPTOR INHIBITS TUMOR-GROWTH, METASTASIS, AND MORTALITY-RATE, Proceedings of the National Academy of Sciences of the United Statesof America, 95(15), 1998, pp. 8795-8800

Authors: HAMA S HEIKE Y NARUSE I TAKAHASHI M YOSHIOKA H ARITA K KURISU K GOLDMAN CK CURIEL DT SAIJO N
Citation: S. Hama et al., ADENOVIRUS-MEDIATED P16 GENE-TRANSFER PREVENTS DRUG-INDUCED CELL-DEATH THROUGH G(1) ARREST IN HUMAN GLIOMA-CELLS, International journal of cancer, 77(1), 1998, pp. 47-54

Authors: FENG MZ JACKSON WH GOLDMAN CK RANCOURT C WANG MH DUSING SK SIEGAL G CURIEL DT
Citation: Mz. Feng et al., STABLE IN-VIVO GENE TRANSDUCTION VIA A NOVEL ADENOVIRAL RETROVIRAL CHIMERIC VECTOR/, Nature biotechnology, 15(9), 1997, pp. 866-870

Authors: GOLDMAN CK SOROCEANU L SMITH N GILLESPIE GY SHAW W BURGESS S BILBAO G CURIEL DT
Citation: Ck. Goldman et al., IN-VITRO AND IN-VIVO GENE DELIVERY MEDIATED BY A SYNTHETIC POLYCATIONIC AMINO POLYMER, Nature biotechnology, 15(5), 1997, pp. 462-466

Authors: CAMPAIN JA GOLDMAN CK ROGERS B MATASSA AA SOSNOWSKI B HARRISON GS CURIEL DT
Citation: Ja. Campain et al., USE OF TROPISM MODIFIED ADENOVIRUSES FOR TARGETED DNA DELIVERY TO AIDS-KS CELLS VIA THE FIBROBLAST GROWTH FACTOR-RECEPTOR PATHWAY, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 45-45

Authors: HOLM PS GOLDMAN CK DIETEL M CURIEL DT
Citation: Ps. Holm et al., INHIBITION OF THE MULTIDRUG-RESISTANCE PHENOTYPE BY ADENOVIRAL DELIVERY OF AN ANTI-MDR RIBOZYME, Cancer gene therapy, 4(5), 1997, pp. 305-305

Authors: GOLDMAN CK BHARARA S PALMER CA VITEK J TSAI JC WEISS HL GILLESPIE GY
Citation: Ck. Goldman et al., BRAIN EDEMA IN MENINGIOMAS IS ASSOCIATED WITH INCREASED VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION, Neurosurgery, 40(6), 1997, pp. 1269-1277

Authors: DAMJANOVICH S BENE L MATKO J ALILECHE A GOLDMAN CK SHARROW S WALDMANN TA
Citation: S. Damjanovich et al., PREASSEMBLY OF INTERLEUKIN-2 (IL-2) RECEPTOR SUBUNITS ON RESTING KIT-225 K6 T-CELLS AND THEIR MODULATION BY IL-2, IL-7, AND IL-15 - A FLUORESCENCE RESONANCE ENERGY-TRANSFER STUDY, Proceedings of the National Academy of Sciences of the United Statesof America, 94(24), 1997, pp. 13134-13139

Authors: GOLDMAN CK ROGERS BE DOUGLAS JT SOSNOWSKI BA YING WB SIEGAL GP BAIRD A CAMPAIN JA CURIEL DT
Citation: Ck. Goldman et al., TARGETED GENE DELIVERY TO KAPOSIS-SARCOMA CELLS VIA THE FIBROBLAST GROWTH-FACTOR RECEPTOR, Cancer research, 57(8), 1997, pp. 1447-1451

Authors: DIETEL M HOLM PS GOLDMAN CK CURIEL D
Citation: M. Dietel et al., ADENOVIRAL TRANSFER OF AN ANTI-MDR1 RIBOZYME TO REVERSE THE MULTIDRUG-RESISTANT PHENOTYPE, Cancer gene therapy, 3(6), 1996, pp. 92-92

Authors: CARRASQUILLO JA WHITE JD PAIK CH LE N ROTMAN M GOLDMAN CK BRECHBIEL MW GANSOW OA TOP LE REYNOLDS JC NELSON DL WALDMANN TA
Citation: Ja. Carrasquillo et al., BIODISTRIBUTION OF IN-111 VS Y-90 LABELED ANTI-TAC MONOCLONAL-ANTIBODY, The Journal of nuclear medicine, 37(5), 1996, pp. 1055-1055

Authors: GOLDMAN CK GILLESPIE GY
Citation: Ck. Goldman et Gy. Gillespie, PHYSIOLOGICAL-RESPONSES OF REVC, A CONTINUOUS RABBIT ENDOTHELIAL VASCULAR CELL, Journal of vascular research, 32(1), 1995, pp. 31-40

Authors: TSAI JC GOLDMAN CK GILLESPIE GY
Citation: Jc. Tsai et al., VASCULAR ENDOTHELIAL GROWTH-FACTOR IN HUMAN GLIOMA CELL-LINES - INDUCED SECRETION BY EGF, PDGF-BB, AND BFGF, Journal of neurosurgery, 82(5), 1995, pp. 864-873

Authors: WALDMANN TA WHITE JD CARRASQUILLO JA REYNOLDS JC PAIK CH GANSOW OA BRECHBIEL MW JAFFE ES FLEISHER TA GOLDMAN CK TOP LE BAMFORD R ZAKNOEN S ROESSLER E KASTENSPORTES C ENGLAND R LITOU H JOHNSON JA JACKSONWHITE T MANNS A HANCHARD B JUNGHANS RP NELSON DL
Citation: Ta. Waldmann et al., RADIOIMMUNOTHERAPY OF INTERLEUKIN-2R-ALPHA-EXPRESSING ADULT T-CELL LEUKEMIA WITH YTTRIUM-90-LABELED ANTI-TAC, Blood, 86(11), 1995, pp. 4063-4075

Authors: BURTON JD BAMFORD RN PETERS C GRANT AJ KURYS G GOLDMAN CK BRENNAN J ROESSLER E WALDMANN TA
Citation: Jd. Burton et al., A LYMPHOKINE, PROVISIONALLY DESIGNATED INTERLEUKIN-T AND PRODUCED BY A HUMAN ADULT T-CELL LEUKEMIA LINE, STIMULATES T-CELL PROLIFERATION AND THE INDUCTION OF LYMPHOKINE-ACTIVATED KILLER-CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 91(11), 1994, pp. 4935-4939

Authors: BAMFORD RN GRANT AJ BURTON JD PETERS C KURYS G GOLDMAN CK BRENNAN J ROESSLER E WALDMANN TA
Citation: Rn. Bamford et al., THE INTERLEUKIN (IL)-2 RECEPTOR-BETA CHAIN IS SHARED BY IL-2 AND A CYTOKINE, PROVISIONALLY DESIGNATED IL-T, THAT STIMULATES T-CELL PROLIFERATION AND THE INDUCTION OF LYMPHOKINE-ACTIVATED KILLER-CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 91(11), 1994, pp. 4940-4944

Authors: TINUBU SA HAKIMI J KONDAS JA BAILON P FAMILLETTI PC SPENCE C CRITTENDEN MD PARENTEAU GL DIRBAS FM TSUDO M BACHER JD KASTENSPORTES C MARTINUCCI JL GOLDMAN CK CLARK RE WALDMANN TA
Citation: Sa. Tinubu et al., HUMANIZED ANTIBODY-DIRECTED TO THE IL-2 RECEPTOR BETA-CHAIN PROLONGS PRIMATE CARDIAC ALLOGRAFT SURVIVAL, The Journal of immunology, 153(9), 1994, pp. 4330-4338

Authors: BURTON JD BAMFORD RN PETERS C GRANT AJ KURYS G GOLDMAN CK BRENNAN J ROESSLER E WALDMANN TA
Citation: Jd. Burton et al., A NOVEL CYTOKINE PROVISIONALLY TERMED IL-T THAT STIMULATES T-CELL ANDLAK ACTIVITY REQUIRES IL-2R-BETA FOR ITS ACTION, Clinical research, 42(2), 1994, pp. 10000305-10000305

Authors: WALDMANN TA GOLDMAN CK TOP L GANSOW O KASTENSPORTES C ROESSLER E ZAKNOEN S WHITE J HORAK I CARRASQUILLO JA REYNOLDS JC NELSON DL
Citation: Ta. Waldmann et al., THE TREATMENT OF HTLV-I-ASSOCIATED ADULT T-CELL LEUKEMIA (ATL) WITH GENETICALLY ENGINEERED MONOCLONAL-ANTIBODIES ARMED WITH RADIONUCLIDES, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 671-671

Authors: WALDMANN TA WHITE JD GOLDMAN CK TOP L GRANT A BAMFORD R ROESSLER E HORAK ID ZAKNOEN S KASTENSPORTES C ENGLAND R HORAK E MISHRA B DIPRE M HALE P FLEISHER TA JUNGHANS RP JAFFE ES NELSON DL
Citation: Ta. Waldmann et al., THE INTERLEUKIN-2 RECEPTOR - A TARGET FOR MONOCLONAL-ANTIBODY TREATMENT OF HUMAN T-CELL LYMPHOTROPHIC VIRUS-I-INDUCED ADULT T-CELL LEUKEMIA, Blood, 82(6), 1993, pp. 1701-1712

Authors: DEBATIN KM GOLDMAN CK WALDMANN TA KRAMMER PH
Citation: Km. Debatin et al., APO-1-INDUCED APOPTOSIS OF LEUKEMIA-CELLS FROM PATIENTS WITH ADULT T-CELL LEUKEMIA, Blood, 81(11), 1993, pp. 2972-2977
Risultati: 1-23 |